FinnGen research project is an expedition to the frontier of genomics and medicine

New result release!

FinnGen DF8 (N=342,499) GWAS results and summary statistics are now available!

FinnGen brings together the nation-wide network of Finnish biobanks.

Every Finn can be a part of the FinnGen study by giving a biobank consent.

Samples available

546 800

Samples needed by 2023: 520 000

Current data freeze

429 200

combined genotype and health registry data

Samples from biobanks

The FinnGen study will utilise samples collected by a nationwide network of Finnish biobanks. The study is based on combining genome information with digital health care data from national health registries.

Take part

Samples are needed from all over Finland in the thousands, because solutions in the field of personalized healthcare can be found only by looking at large masses. Every Finn can be a part of the FinnGen study by giving a biobank consent.

Everybody benefits

The genome data produced during the project will be owned by the Finnish biobanks, and remain available for researcher purposes. The medical breakthroughs that arise from the project will eventually benefit health care systems and patients globally.

Collaboration is the key

The collaborative nature of the FinnGen research project is exceptional compared to many other studies. The study involves all the same actors as drug development. With this open cooperation, we hope to speed up the emergence of new innovations.

Data freeze 8 results and summary statistics available!

Results can be browsed online using the FinnGen web browser and the summary statistics downloaded

This data freeze consists of >342,000 individuals, almost 20.2 M variants and 2,202 disease endpoints. To get more information about how to access the results and summary statistics, please follow this link:

Access results

Birches with the text "New FinnGen GWAS results".

News

Family history is not sufficient for assessing inherited disease risk

A new study from the University of Helsinki demonstrates the added value of genetic information in measuring inherited disease risk, alongside the widely used assessment of family history.

10.11.2022

New gene variant that protects against coronary heart disease uncovered

A variant typical of the Finnish population that protects against heart diseases was identified in the FinnGen genomic study coordinated by the University of Helsinki. The risk of developing heart diseases is roughly one-fifth lower in carriers of the variant compared to the population on average.

A human holding a green leaf, with a shape of a heart,

17.8.2022

Tweets by FinnGen_FI